Sawai (SWGHF) USPTO patents

Utility

Additive composition for orally disintegrating tablet

9 Nov 21

Provided is a novel additive for an orally disintegrating tablet providing quick disintegrability and tablet hardness to the orally disintegrating tablet, and a producing method therefor.

Yoichi Higashiyama, Wataru Izui, Ayako Harada, Satoru Ogihara, Kenji Nozawa, Hiroaki Kikuoka

Filed: 6 Mar 19

Utility

Method for Producing Granules Containing a Core Particle, Granules Containing a Core Particle, Pharmaceutical Composition Containing the Granules Containing the Core Particle, and Preparation Containing the Pharmaceutical Composition

19 Aug 21

A method for producing granules containing a core particle by using a general granulation method is provided.

Wataru IZUI, Kenji NOZAWA, Hiroyuki YAMAMOTO, Ryota KIMATA, Naoki YOSHIHARA

Filed: 8 Feb 21

Utility

595d9cnw379be2sq wyorh9dmkgp37s

27 Apr 21

Masatoshi Nakatani, Masaru Sugita, Nobuaki Ikeji, Kenji Nozawa

Filed: 25 Oct 18

Utility

tu2n215mu1v7lvrxfs52er

23 Feb 21

To provide a mirabegron-containing tablet that maintains the amorphous form of mirabegron even after long-term storage.

Toshihiro Yanagi, Kenji Nozawa, Kaori Umemura, Masatoshi Arimura, Akiko Takada

Filed: 28 Feb 18

Utility

9oi1mws2kfkyr14w2opc0

12 Jan 21

A mouthfeel evaluation method for an orally disintegrating test object is provided, the method including, by a measurement apparatus, giving a predetermined distortion with a predetermine cycle as applying a predetermined pressure to the orally disintegrating test object, adding a predetermined amount of a test liquid to the test object, and measuring a loss tangent of the test object with time.

Masatoshi Nakatani, Masaru Sugita, Nobuaki Ikeji, Hiroaki Kikuoka

Filed: 25 Jan 19

Utility

qy36luo5ym0n0p8pivrbfcqinpesv0 rmhynsmypz0x060ssssjyou

23 Nov 20

A sustained-release preparation containing pseudoephedrine is provided comprising pseudoephedrine or a pharmaceutically acceptable salt thereof, and a hardened oil or stearic acid.

Yuki Nishikawa, Hiroaki Kikuoka, Michinori Oikawa, Hiroyuki Yamamoto, Tomoya Nakagawa

Filed: 19 Jun 19

Utility

lo5of4f8eslcihynikql2sy5h936ihg9rwvsdgyc1x4kgh1d6l8

9 Sep 20

An anhydrous dasatinib-containing preparation comprising an anhydrous dasatinib and a titanium oxide or colorant or antioxidant is provided.

Michinori OIKAWA, Hiroyuki YAMAMOTO, Hiroaki KIKUOKA

Filed: 19 May 20